Physician profile
John Abroon
NPI 1588750434
$26,754.57
in general payments reported to CMS, 2019-2025
52 companies · $4,608 in 2025
The $4,608 reported for 2025 was more than what 97% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,695 · 2020: $1,984 · 2021: $4,577 · 2022: $3,301 · 2023: $4,838 · 2024: $3,751 · 2025: $4,608.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13K · Education: $69.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13,127.76 |
| Education | $69.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $4,782.62 | 2019-2025 | Jardiance |
| Abbvie INC. | $2,675.02 | 2019-2025 | Ubrelvy, Qulipta |
| Intra-Sana Laboratories | $2,432.28 | 2023-2025 | Reltone 400 Mg, Reltone 200 Mg, Glycate |
| Astrazeneca Pharmaceuticals Lp | $1,907.44 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Corcept Therapeutics | $1,322.87 | 2019-2023 | Korlym |
| Xeris Pharmaceuticals, INC. | $1,126.85 | 2023-2025 | Gvoke Hypopen, Recorlev |
| Circassia INC. | $1,107.66 | 2019 | |
| Novo Nordisk INC | $1,033.36 | 2020-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $1,027.78 | 2019-2025 | Tepezza, Repatha, Repatha |
| Pfizer INC. | $728.99 | 2019-2025 | |
| Lilly USA, LLC | $657.53 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Janssen Pharmaceuticals, INC | $590.58 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $569.66 | 2021-2024 | |
| Biohaven Pharmaceuticals, INC. | $489.94 | 2021 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $421.11 | 2022 |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Idorsia Pharmaceuticals US INC | $401.82 | 2022-2024 | Quviviq |
| Allergan, INC. | $365.09 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $338.74 | 2019-2024 | Cycloset, Xifaxan |
| Abbott Laboratories | $311.68 | 2021 | |
| Merck Sharp & Dohme LLC | $307.42 | 2019-2023 | Dificid |
| Madrigal Pharmaceuticals | $282.35 | 2025 | Rezdiffra |
| Bausch Health US, LLC | $256.68 | 2021-2023 | Wellbutrin, Aplenzin |
| Ascendis Pharma Endocrinology INC | $249.97 | 2023-2025 | Yorvipath |
| Cequr Corporation | $219.16 | 2023 | Cequr Simplicity |
| E.R. Squibb & Sons, L.L.C. | $199.59 | 2024-2025 | Camzyos, Eliquis |
| Boston Scientific Corporation | $195.54 | 2025 | Ams 700 |
| Eisai INC. | $190.87 | 2025 | |
| Astellas Pharma US INC | $189.25 | 2024-2025 | Veozah |
| Heartflow, INC. | $177.44 | 2024-2025 | |
| Biotronik INC. | $177.29 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $154.17 | 2019-2021 | |
| Glaxosmithkline, LLC. | $149.05 | 2019-2023 | Arexvy, Shingrix |
| Gilead Sciences, INC. | $147.82 | 2019 | |
| Zealand Pharma US, INC. | $146.25 | 2020-2021 | |
| Exact Sciences Corporation | $146.16 | 2025 | Cologuard Collection Kit |
| Forte Bio-Pharma LLC | $135.73 | 2025 | Prolate, Tanlor, Nalocet |
| Beta Bionics, INC. | $134.17 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Arbor Pharmaceuticals, INC. | $133.79 | 2019-2020 | |
| Amryt Pharma Holdings Ltd | $128.51 | 2023 | Mycapssa |
| Medtronic, INC. | $124.88 | 2021 | |
| Esperion Therapeutics, INC. | $107.20 | 2024-2025 | Nexletol |
| Genzyme Corporation | $100.70 | 2024 | |
| Intuity Medical INC | $97.51 | 2022 | |
| Phathom Pharmaceuticals, INC. | $86.45 | 2024 | Voquezna |
| Sanofi-Aventis U.S. LLC | $63.86 | 2025 | |
| Redhill Biopharma INC. | $43.05 | 2020-2022 | |
| Currax Pharmaceuticals LLC | $31.78 | 2021-2022 | |
| Antares Pharma, INC. | $23.95 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $16.30 | 2020 | |
| Celgene Corporation | $16.06 | 2019 | |
| Ironwood Pharmaceuticals, INC | $15.34 | 2021 | |
| Metuchen Pharmaceuticals | $15.26 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Abroon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.